We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Collection of Autologous Blood Products by Double Erythrocytapheresis

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00202475
First Posted: September 20, 2005
Last Update Posted: October 20, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Atrium Medical Center
Maasland Hospital
Information provided by:
Sanquin Research & Blood Bank Divisions
  Purpose
The project will determine the advantages of double erythrocytapheresis in the collection of preoperative autologous erythrocytes as compared to the standard collections of whole blood. The study will assess the total reduction in the number of procedures required to obtain the preoperative units ordered by the surgeon. Also, successfulness of erythrocytaphereses versus classical whole blood collection for these patients will be compared.

Condition Intervention Phase
Pre Operative Autologous Donation Procedure: eythrocytapheresis Procedure: whole blood collection Phase 3

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Collection of Autologous Blood Products by Double Erythrocytapheresis - Cost Effectiveness Study

Further study details as provided by Sanquin Research & Blood Bank Divisions:

Primary Outcome Measures:
  • decline in Hemoglobine levels [ Time Frame: surgery ]

Secondary Outcome Measures:
  • Storage parameters- ATP [ Time Frame: 35 days ]

Enrollment: 100
Study Start Date: September 2003
Study Completion Date: December 2007
Primary Completion Date: September 2006 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: 1 Procedure: eythrocytapheresis
machinal collection of erythrocytes
Other Name: apheresis
Active Comparator: 2 Procedure: whole blood collection
collection of whole blood
Other Name: blood donation

Detailed Description:
The project will determine the advantages of double erythrocytapheresis in the collection of preoperative autologous erythrocytes as compared to the standard collections of whole blood. The study will assess the total reduction in the number of procedures required to obtain the preoperative units ordered by the surgeon. Also, successfulness of erythrocytaphereses versus classical whole blood collection for these patients will be compared.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Elective surgery

Exclusion Criteria:

  • Malignancies
  • Severe arrhythmias
  • Congestive heart failure
  • Recent angina
  • Epileptic seizures in the last 3 months before collection
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00202475


Locations
Netherlands
Sanquin Bloodbank
Maastricht, Limburg, Netherlands, 6229 GS
Sanquin Blood Bank Southeast Region
Maastricht, Netherlands, 6229 GR
Sponsors and Collaborators
Sanquin Research & Blood Bank Divisions
Atrium Medical Center
Maasland Hospital
Investigators
Principal Investigator: Eva Rombout, MD Sanquin Research and Blood Bank Divisions
  More Information

Additional Information:
Responsible Party: Dr. Wim de Kort PhD, Sanquin Blood BankDivision South-east
ClinicalTrials.gov Identifier: NCT00202475     History of Changes
Other Study ID Numbers: PPO-C-02-15
First Submitted: September 13, 2005
First Posted: September 20, 2005
Last Update Posted: October 20, 2009
Last Verified: October 2009

Keywords provided by Sanquin Research & Blood Bank Divisions:
Dubble eerythrocytapheresis